The chemical class known as TPTE activators encompasses a variety of compounds that can influence the activity of the TPTE protein, a member of the tyrosine phosphatase family. These activators are defined not by a shared chemical structure, but rather by their ability to modulate the biochemical pathways that govern the activity of TPTE. The primary mechanism by which these activators exert their influence is through the alteration of cellular signaling cascades that can lead to an increase in the activity of TPTE. The activators operate within the complex network of intracellular communication, often targeting upstream components of signaling pathways or altering the balance of secondary messengers that, in turn, regulate the function of TPTE.
In the realm of cellular signaling, these activators can act on various points of regulation, including enzyme inhibition, cofactor modulation, and alteration of substrate availability. For instance, some activators function by inhibiting phosphatases that act in opposition to TPTE, thereby shifting the equilibrium toward a more active state of TPTE. Others can bind to allosteric sites on key regulatory proteins, inducing conformational changes that can translate to changes in TPTE activity. Additionally, certain activators alter the levels of lipids that serve as substrates or secondary messengers in TPTE-related pathways, thus indirectly modulating the activity of TPTE. These activators are integral to the fine-tuning of signal transduction and play a role in the dynamic regulation of TPTE within cellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor; by altering PI3K activity, it can modulate pathways connected to TPTE's role in the cell. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This compound is a selective inhibitor of PI3K, impacting phosphoinositide levels and subsequent signaling pathways where TPTE may function. | ||||||
BX 795 | 702675-74-9 | sc-281689 sc-281689A sc-281689C sc-281689B sc-281689D sc-281689E | 2 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $219.00 $273.00 $331.00 $495.00 $882.00 $1489.00 | 5 | |
SF1670 inhibits PTEN, another phosphatase, which can lead to changes in phosphatidylinositol signaling, potentially affecting TPTE. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
Perifosine is an AKT pathway inhibitor, which can lead to alterations in downstream signaling, possibly impacting TPTE. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can influence cellular processes that may affect TPTE activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like okadaic acid, inhibits protein phosphatases, potentially affecting pathways associated with TPTE. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions are cofactors for many phosphatases; they can modulate the enzyme activity and may influence TPTE's functionality. | ||||||